NEW YORK–(BUSINESS WIRE)–Haymarket Media, Inc. is pleased to announce that it has acquired the American Journal of Endocannabinoid Medicine (AJEM)—a peer-reviewed journal focused on cannabinoid medicine. Haymarket is making an additional investment in AJEM to increase its engagement with healthcare professionals (HCPs) and fulfill its mission to educate and inform the medical community on cannabinoid-based therapy. Physicians are not trained in the endocannabinoid system (ECS) in medical scho
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Aelis Farma Publishes Half-Year Financial Results for 2023 and Confirms Its Development Objectives
- Leafly Challenges Certain New York Cannabis Regulations; Court Enters Order Blocking Enforcement
- Green Check Honored With PBC Top Compliance Company Award
- Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
- Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
More from this user
